Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Amortization of Deferred Charges (2021 - 2025)

Historic Amortization of Deferred Charges for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to $1.3 million.

  • Core Scientific's Amortization of Deferred Charges fell 1841.94% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 451.26%. This contributed to the annual value of $3.8 million for FY2024, which is 39946.81% up from last year.
  • According to the latest figures from Q3 2025, Core Scientific's Amortization of Deferred Charges is $1.3 million, which was down 1841.94% from $1.6 million recorded in Q2 2025.
  • Core Scientific's 5-year Amortization of Deferred Charges high stood at $6.2 million for Q4 2021, and its period low was -$190000.0 during Q4 2024.
  • Over the past 5 years, Core Scientific's median Amortization of Deferred Charges value was $1.2 million (recorded in 2022), while the average stood at $1.5 million.
  • Per our database at Business Quant, Core Scientific's Amortization of Deferred Charges skyrocketed by 135376.88% in 2022 and then tumbled by 12526.6% in 2024.
  • Quarter analysis of 5 years shows Core Scientific's Amortization of Deferred Charges stood at $6.2 million in 2021, then tumbled by 84.59% to $963000.0 in 2022, then fell by 21.91% to $752000.0 in 2023, then tumbled by 125.27% to -$190000.0 in 2024, then surged by 790.0% to $1.3 million in 2025.
  • Its last three reported values are $1.3 million in Q3 2025, $1.6 million for Q2 2025, and $1.7 million during Q1 2025.